查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1796885

女性科技市場－全球產業規模、佔有率、趨勢、機會和預測（按產品、應用、最終用途、地區和競爭細分，2020-2030 年）

Female Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End-use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球女性科技 (Femtech) 市場價值為 393.4 億美元，預計到 2030 年將達到 978.8 億美元，預測期內的複合年成長率為 16.41%。受數位素養率、網路連線、智慧型手機普及率和數位醫療基礎設施不斷提高的推動，全球女性科技 (Femtech) 市場正在經歷顯著成長。此外，健身追蹤器和智慧手錶等智慧穿戴裝置的日益普及預計將促進女性科技 (Femtech) 市場的成長。此外，已開發國家和發展中國家擴大採用數位解決方案，加上技術的進步，預計將在預測期內推動市場成長。 FemTech（女性科技）是一項改善女性健康與福祉的科技。這個術語經常用於指旨在增強或支持女性健康的計劃、服務、產品、軟體、硬體、維生素、補充劑、遠距醫療、穿戴式裝置、數位平台和消費品，包括但不限於那些認定為順性別女性和性別或性少數群體的女性。

市場概覽
預測期 2026-2030
2024年市場規模 393.4億美元
2030年市場規模 978.8億美元
2025-2030 年複合年成長率 16.41%
成長最快的領域 懷孕和護理
最大的市場 北美洲

女性科技公司專注於開發滿足女性獨特醫療保健和健康需求的科技產品和服務。隨著人們對女性健康和福祉重要性的認知不斷提高，對女性科技產品的需求也日益成長。此外，由於潛在的豐厚回報，投資人對女性科技公司的投資興趣也日益濃厚。例如，根據PitchBook的數據，2020年女性科技公司獲得了超過8.2億美元的融資。因此，市場中不斷湧現的投資機會預計將支持女性科技市場的成長。

關鍵市場促進因素

女性健康問題日益普遍

主要市場挑戰

醫學研究與設計中的性別偏見

主要市場趨勢

生育和生殖健康解決方案的擴展

目錄

第1章：服務概述

  • 市場定義
  • 市場範圍
    • 覆蓋市場
    • 考慮學習的年限
    • 主要市場區隔

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球女性科技（Femtech）市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按產品（行動應用程式、連接裝置、服務、其他）
    • 依應用（生殖健康、一般健康、懷孕和護理、骨盆和子宮護理）
    • 依最終用途（個人、生育診所、醫院、研究機構、診斷中心）
    • 按地區
    • 按公司分類（2024）
  • 產品圖
    • 按產品
    • 按應用
    • 按最終用途
    • 按地區

第6章：歐洲女性科技（Femtech）市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 英國
    • 義大利
    • 德國
    • 西班牙

第7章：北美女性科技（Femtech）市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第8章：亞太女性科技（Femtech）市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美女性科技（Femtech）市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲女性科技（Femtech）市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 產品發布
  • 併購
  • 技術進步

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章：全球女性科技 (Femtech) 市場：SWOT 分析

第 15 章：競爭格局

  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Flo Health, Inc.
  • Glow, Inc.
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • The Flex Company
  • Thinx, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14399

Global Female Technology (Femtech) Market was valued at USD 39.34 Billion in 2024 and is expected to reach USD 97.88 Billion by 2030 with a CAGR of 16.41% during the forecast period. The global market for Female Technology (Femtech) is experiencing significant growth, driven by the increasing digital literacy rates, internet connectivity, smartphone penetration, and digital healthcare infrastructure. Further, the growing availability of smart wearable devices such as fitness trackers, and smartwatches are anticipated to lift the growth of the Female Technology (Femtech) market. In addition, the increasing adoption of digital solutions in developed and developing countries combined with advancements in technologies is expected to fuel the growth of the market during the forecast period. FemTech (Female Technology) is a technology that improves the health and well-being of women. This term is frequently used to refer to programs, services, products, software, hardware, vitamins, supplements, telehealth, wearables, digital platforms, and consumer goods intended to enhance or support the health of women, including but not limited to those who identify as cisgender women and women from gender or sexual minorities.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 39.34 Billion
Market Size 2030USD 97.88 Billion
CAGR 2025-203016.41%
Fastest Growing SegmentPregnancy and Nursing Care
Largest MarketNorth America

Femtech companies are focused on developing technology products and services that cater to the unique healthcare and wellness needs of women. As awareness about the importance of women's health and well-being increases, so does the demand for Femtech products. Additionally, investors are increasingly interested in investing in Femtech companies due to the potential for significant returns. For instance, in 2020, Femtech companies received over $820 million in funding, according to PitchBook. Hence, rising investment opportunities in the market is anticipated to support the growth of the Female Technology (Femtech) market.

Key Market Drivers

Rising Prevalence of Women's Health Issues

The increasing incidence of women's health conditions is a major catalyst for the growth of the Femtech market. Conditions such as endometriosis, polycystic ovary syndrome (PCOS), and menopause-related complications are becoming more prevalent, necessitating specialized healthcare solutions. According to the World Health Organization (WHO), endometriosis affects approximately 190 million women globally, equating to about 10% of women of reproductive age. This growing burden has highlighted the inadequacies in traditional healthcare systems to address women's specific health needs effectively. Consequently, there is a surge in demand for Femtech solutions that offer personalized care, remote monitoring, and data-driven insights. These technologies empower women to manage their health proactively, leading to better outcomes and increased quality of life.

Governments and healthcare organizations are also recognizing the importance of addressing women's health issues. Initiatives aimed at increasing awareness, funding research, and integrating women's health into broader healthcare policies are gaining momentum. Such support not only validates the significance of Femtech but also provides a conducive environment for its growth and integration into mainstream healthcare.

Key Market Challenges

Gender Bias in Medical Research and Design

A significant challenge facing the Femtech industry is the persistent gender bias in medical research and product design. Historically, medical studies have predominantly focused on male subjects, leading to a lack of comprehensive understanding of female physiology and health conditions. This oversight results in the development of healthcare solutions that may not effectively address women's specific needs. In the context of Femtech, this bias manifests in products that are not adequately tested or tailored for women, potentially compromising their efficacy and safety. Furthermore, the underrepresentation of women in clinical trials and research studies perpetuates this cycle, hindering the advancement of evidence-based solutions in women's health.

Addressing this challenge requires a concerted effort to prioritize gender-inclusive research and development. This includes ensuring diverse representation in clinical studies, investing in research focused on women's health issues, and involving women in the design and testing of healthcare technologies. Governmental policies and funding initiatives that support such inclusive practices are essential to overcoming this barrier and fostering innovation in the Femtech sector.

Key Market Trends

Expansion of Fertility and Reproductive Health Solutions

The Femtech market is witnessing a significant trend towards the expansion of fertility and reproductive health solutions. With societal shifts leading to delayed childbearing and increased awareness of reproductive health, there is a growing demand for technologies that assist in fertility tracking, conception, and overall reproductive wellness. Innovations in this space include mobile applications that monitor ovulation cycles, wearable devices that track physiological indicators, and telemedicine platforms offering consultations with fertility specialists. These tools empower women with information and support, enabling informed decisions about their reproductive health.

Furthermore, the integration of artificial intelligence (AI) and machine learning into these solutions enhances their predictive capabilities, offering personalized recommendations and early detection of potential issues. This technological advancement not only improves user experience but also increases the efficacy of fertility treatments. Healthcare providers and policymakers are also recognizing the importance of reproductive health, leading to increased funding and supportive regulations. Such initiatives facilitate the development and accessibility of fertility-focused Femtech solutions, contributing to the overall growth of the market.

Key Market Players

  • ALYK, Inc.
  • Aytu BioScience, Inc.
  • Biowink GmbH
  • Flo Health, Inc.
  • Glow, Inc.
  • NaturalCycles Nordic AB
  • Ovia Health
  • Plackal Tech
  • The Flex Company
  • Thinx, Inc.

Report Scope:

In this report, the Global Female Technology (Femtech) Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Female Technology (Femtech) Market, By Product:

  • Mobile Apps
  • Connected Devices
  • Services
  • Others

Female Technology (Femtech) Market, By Application:

  • Reproductive Health
  • General Wellness
  • Pregnancy and Nursing Care
  • Pelvic and Uterine Care

Female Technology (Femtech) Market, By End-use:

  • Individuals
  • Fertility Clinics
  • Hospitals and Research Institutes
  • Diagnostic Centers

Female Technology (Femtech) Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Female Technology (Femtech) Market.

Available Customizations:

Global Female Technology (Femtech) Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Service Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Female Technology (Femtech) Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 5.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 5.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Map
    • 5.3.1. By Product
    • 5.3.2. By Application
    • 5.3.3. By End-use
    • 5.3.4. By Region

6. Europe Female Technology (Femtech) Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 6.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 6.2.3. By End-use (Individuals, Fertility Clinics, Hospitals, and Research Institutes, Diagnostic Centers)
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Female Technology (Femtech) Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. United Kingdom Female Technology (Femtech) Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Italy Female Technology (Femtech) Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use
    • 6.3.4. Germany Female Technology (Femtech) Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Product
        • 6.3.4.2.2. By Application
        • 6.3.4.2.3. By End-use
    • 6.3.5. Spain Female Technology (Femtech) Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Product
        • 6.3.5.2.2. By Application
        • 6.3.5.2.3. By End-use

7. North America Female Technology (Femtech) Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 7.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 7.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Female Technology (Femtech) Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. Mexico Female Technology (Femtech) Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. Canada Female Technology (Femtech) Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use

8. Asia-Pacific Female Technology (Femtech) Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 8.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 8.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Female Technology (Femtech) Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India Female Technology (Femtech) Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan Female Technology (Femtech) Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea Female Technology (Femtech) Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia Female Technology (Femtech) Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. South America Female Technology (Femtech) Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 9.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 9.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Female Technology (Femtech) Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina Female Technology (Femtech) Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia Female Technology (Femtech) Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. Middle East and Africa Female Technology (Femtech) Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product (Mobile Apps, Connected Devices, Services, Others)
    • 10.2.2. By Application (Reproductive Health, General Wellness, Pregnancy, and Nursing Care, Pelvic and Uterine Care)
    • 10.2.3. By End-use (Individuals, Fertility Clinics, Hospitals and Research Institutes, Diagnostic Centers)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Female Technology (Femtech) Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. UAE Female Technology (Femtech) Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. Saudi Arabia Female Technology (Femtech) Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Product Launches
  • 12.2. Mergers & Acquisitions
  • 12.3. Technological Advancements

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Female Technology (Femtech) Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. ALYK, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Aytu BioScience, Inc.
  • 15.3. Biowink GmbH
  • 15.4. Flo Health, Inc.
  • 15.5. Glow, Inc.
  • 15.6. NaturalCycles Nordic AB
  • 15.7. Ovia Health
  • 15.8. Plackal Tech
  • 15.9. The Flex Company
  • 15.10. Thinx, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer